Figure 2
Figure 2. Phenotypic characterization of TIMP-1−/− stem and progenitor cells. (A-B) Percentages and absolute numbers of BM SPKLS HSCs from WT and TIMP-1−/− mice. (C-D) Percentages and absolute numbers of BM CD150+48−KSL HSCs from WT and TIMP-1−/− mice. (E) Absolute numbers of BM MMPs, short-term HSCs, and LT-HSCs. (F) Percentage of BM KSLs in WT and TIMP-1−/− mice. (G) Percentage of CLPs and common myeloid (granulocyte macrophage progenitors [GMPs], CMPs, and megakaryocyte-erythroid precursors [MEPs]) progenitors in WT and TIMP-1−/− mice. (H) Percentage of KSL cells in the spleen of WT and TIMP-1−/− mice. Results are reported as mean ± SEM of at least triplicate experiments. *P < .05 and ***P < .001.

Phenotypic characterization of TIMP-1−/− stem and progenitor cells. (A-B) Percentages and absolute numbers of BM SPKLS HSCs from WT and TIMP-1−/− mice. (C-D) Percentages and absolute numbers of BM CD150+48KSL HSCs from WT and TIMP-1−/− mice. (E) Absolute numbers of BM MMPs, short-term HSCs, and LT-HSCs. (F) Percentage of BM KSLs in WT and TIMP-1−/− mice. (G) Percentage of CLPs and common myeloid (granulocyte macrophage progenitors [GMPs], CMPs, and megakaryocyte-erythroid precursors [MEPs]) progenitors in WT and TIMP-1−/− mice. (H) Percentage of KSL cells in the spleen of WT and TIMP-1−/− mice. Results are reported as mean ± SEM of at least triplicate experiments. *P < .05 and ***P < .001.

Close Modal

or Create an Account

Close Modal
Close Modal